在墨西哥蒂华纳为补充和替代癌症治疗提供众筹资金:内容分析
Jeremy Snyder1, Marco Zenone2, Ashmita Grewal1
1Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
JMIR cancer
|August 14, 2024
概括
患者在墨西哥蒂华纳寻求补充和替代医学 (CAM) 癌症治疗,通常是由于感知到的疗效和不那么侵入性的选择. 众筹活动凸显了国外对这些疗法的需求.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医学经济学 医学经济学
背景情况:
- 补充和替代医学 (CAM) 癌症治疗经常没有保险覆盖,导致患者寻求经济援助.
- 众筹已经成为患者为昂贵的CAM癌症疗法提供资金的重要途径.
- 墨西哥蒂华纳是寻求CAM癌症治疗的患者的重要目的地.
研究的目的:
- 为了调查在墨西哥蒂华纳寻求CAM癌症治疗的患者背后的动机.
- 分析支持CAM癌症治疗的众筹活动,以了解患者的理由.
- 确定影响CAM疗法和国际治疗中心选择的关键因素.
主要方法:
- 在2022年1月至2023年2月期间,为与蒂华纳的CAM癌症诊所相关的运动筹集众筹平台 (GoFundMe,GiveSendGo).
- 开发了一个编码框架,以确定患者在国外寻求CAM治疗的理由.
- 编码的竞选元数据,包括癌症阶段,类型,所寻求的治疗和受益人群.
主要成果:
- 在蒂华纳寻求CAM治疗的主要理由包括感知到的疗效 (29.9%),缺乏治疗国内选择 (23.2%),整体/精神护理 (20.1%) 和非有毒/自然治疗 (18.2%).
- 众筹活动筹集了超过520万美元.
- 受益者主要是女性 (69.7%) 和白人 (71.1%).
结论:
- 在蒂华纳,为CAM癌症治疗进行众筹活动往往会宣传有关治疗疗效的错误信息.
- 这些活动将资金和赞同转移到墨西哥的CAM诊所,这可能对患者产生负面影响.
- 尽管有财政短缺和风险,蒂华纳仍然是国际CAM癌症治疗的热门目的地.
关键词:
这就是为什么CAMCAMCAM是CAMCAM.在CAM癌症治疗中,CAM癌症的治疗方法.给 发送 去 发送在 GoFundMe 上提供资金.墨西哥 墨西哥 墨西哥 墨西哥蒂华纳 (Tijuana) 是一个小镇.替代护理服务提供者替代性癌症疗法 替代性癌症治疗活动活动活动.癌症 癌症 癌症 癌症 癌症癌症诊所 癌症诊所癌症治疗 治疗 治疗 癌症众筹 (crowdfunding) 是一种众筹方式.众筹平台 众筹平台金融毒性 金融毒性保险保险的保险是什么意思国际医疗旅游国际医疗旅游互联网研究互联网研究医疗干预是一种医疗干预.错误的信息 错误的信息病人的病人的病人的病.患者患者患者患者患者患者患者妇女的健康妇女的健康更多相关视频
10:55Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System
Published on: January 8, 2018
11.1K
07:49Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
124
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
